Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2005
02/24/2005US20050044580 Methods and compositions for diagnosing and treating disorders involving angiogenesis
02/24/2005US20050043527 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
02/24/2005US20050043526 Sigma factor A (SIGA) protein for use as tool in expression of operons associated with lysine biosynthesis; ennhancing animal feeds; cosmetics; medicine
02/24/2005US20050043525 Nucleotide sequences coding amidotransferase for use in identifying modulator for use in identifying microbiocides, fungicides and/or herbicidal agents
02/24/2005US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/24/2005US20050043297 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
02/24/2005US20050043265 High affinity RNA ligands of basic fibroblast growth factor
02/24/2005US20050043259 Using transfer rna splicing endonuclease and oligonucleotide probes to preferentially locate, hybridize and split target messenger rna sequences comprising bulge-helix-bulge conformations
02/24/2005US20050043256 antisense oligonucleotides, are targeted to a nucleic acid encoding stearoyl-CoA desaturase, and modulate the expression of stearoyl-CoA desaturase; gene therapy; genetic engineering; for treatment of abnormal lipid metabolism, obesity
02/24/2005US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer
02/24/2005US20050043232 Metalloprotease activation of myostatin, and methods of modulating myostatin activity
02/24/2005US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics
02/24/2005US20050042739 Enzymatic polypeptide for use as tool in identifying modulator for treatment and prevention of immunological and viral diseases
02/24/2005US20050042737 Starch process
02/24/2005US20050042735 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
02/24/2005US20050042734 incubation of starches, maltodextrins or glycogen with an ammonium source in a reaction mixture contaiinig cell extracts comprising glucosamine-6-phosphate deaminase activity, to form glucosamine-6-phosphate
02/24/2005US20050042730 Gene screening method using nuclear receptor
02/24/2005US20050042727 UDP-N-acetylglucosamine: galactose-Beta 1,3-N-A-acetylgalactosamine-alpha-R/N-acetylglucosamine-Beta 1,3-N-acetylgalactosamine-alpha-R (GIcNAc to GalNac) Beta 1,6-N-acetylglucosaminyltransferase, C2/4GnT
02/24/2005US20050042722 Isolated nucleic acid encoding enzyme; chimera gene expression; genetic engineering
02/24/2005US20050042706 Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics
02/24/2005US20050042684 Binding phenol oxidizing enzyme-peptide complexes
02/24/2005US20050042681 Methods and formulations for diagnosing, monitoring, staging and treating heart failure
02/24/2005US20050042670 Peptides associated with carboxypeptidase active site for use in identification of modulators for treatment of cell proliferative disorders
02/24/2005US20050042648 Vitro sorting method
02/24/2005US20050042645 Expression vector comprising nucleotide sequences coding nitric oxide synthase for use in preparation of herbicides, antibiotics, nematicides, fungicides, insecticides and anticancer agents
02/24/2005US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
02/24/2005US20050042629 Nucleotide sequence coding heat resistant polymerase for use as processivity and replication tool in DNA amplification
02/24/2005US20050042626 Novel human kinase proteins and polynucleotides encoding the same
02/24/2005US20050042624 Tumor antigen
02/24/2005US20050042607 Parkin protein as ubiquitin ligase
02/24/2005US20050042328 Culture product; yeast extracts; for food, beverages
02/24/2005US20050042305 Cutting particle sizes; solvent extraction; reduced ribonuclease activity activation
02/24/2005US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection
02/24/2005US20050042222 Methods of diagnosing thyroid carcinoma
02/24/2005US20050042213 Administering rhodanine derivative and O,O*-dihydroxybenzenebis(p-amidophenol) derivative; metabolic, neurodegenerative and autoimmune diseases; wound healing, antiinflammatory, and anticarcinogenic agents; atherosclerosis, restenosis, nephropathy
02/24/2005DE10006462B4 Produktion nicht-kariogener Zucker in transgenen Pflanzen Non-cariogenic sugar production in transgenic plants
02/24/2005CA2852159A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
02/24/2005CA2535255A1 Improved halohydrin dehalogenases and related polynucleotides
02/24/2005CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions
02/24/2005CA2534895A1 Hemostatic compositions containing sterile thrombin
02/24/2005CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins
02/24/2005CA2533910A1 Methods and compositions for amplification of dna
02/24/2005CA2533838A1 Improved ketoreductase polypeptides and related polynucleotides
02/24/2005CA2532557A1 Methods and compositions for determination of glycated proteins
02/24/2005CA2529658A1 Engineering single-gene-controlled staygreen potential into plants
02/24/2005CA2529553A1 Ribonucleases and methods of making them recombinantly
02/24/2005CA2526595A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
02/24/2005CA2525969A1 Intron fusion proteins, and methods of identifying and using same
02/23/2005EP1508805A1 Stabilizing agent and blocking agent
02/23/2005EP1508619A1 Novel promoter
02/23/2005EP1508617A1 Method for stabilizing an alanine aminotransferase and the corresponding compositions
02/23/2005EP1508616A1 Method for stabilizing and aspartate aminotransferase and the corresponding compositions
02/23/2005EP1508573A1 Stabilizing agent for enzymes
02/23/2005EP1508572A1 PROTEIN INDUCING CELL DEATH OF i HELICOBACTER PYLORI /i
02/23/2005EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof
02/23/2005EP1507869A2 Improved receptor detection
02/23/2005EP1507866A2 Carotene synthase gene and uses therefor
02/23/2005EP1507864A1 A method for production of plants with suppressed photorespiration and improved co2 fixation
02/23/2005EP1507858A1 Method for the purification of microbial protease
02/23/2005EP1507857A1 Novel pectinases and uses thereof
02/23/2005EP1507856A1 Regulation of human serine/threonine kinase
02/23/2005EP1507855A2 Elongase genes and uses thereof
02/23/2005EP1507854A1 New improved acyltransferase
02/23/2005EP1507853A1 Palliative treatment for gluten intolerance
02/23/2005EP1507852A2 Nucleic acids and proteins with thioredoxin reductase activity
02/23/2005EP1507804A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
02/23/2005EP1507802A1 Transformed fungi for production of recombinant proteins
02/23/2005EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
02/23/2005EP1507546A2 Methods of using 22417, a novel human aminoprotease family member
02/23/2005CN1585824A Enzymatic process for the manufacture of L-ascorbic acid and D-erythorbic acid
02/23/2005CN1584596A Reagent box for external blood group and blood serum experimental determination
02/23/2005CN1584595A External blood group and blood serum experimental determining method
02/23/2005CN1584034A Corn tyrosin protein phosphatase gene and its coding protein and use
02/23/2005CN1584033A Taxaceae 3-hydroxy-3-methylpentadiacyl cozymase A synthetic zymoprotein coding sequence
02/23/2005CN1584032A Protein coding sequence of protein kinase 3 activated by cell division protoplasm for brassia rape
02/23/2005CN1584026A Production of oligomeric xylose and special immobilized xylanase therefor
02/23/2005CN1584025A Method for extracting cydonic chimosin
02/23/2005CN1584024A Nitrile hydratase and its coding gene and use
02/23/2005CN1584023A Recombined aspergillus oryzae tannase and its expression and purification
02/23/2005CN1190495C Method for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells
02/23/2005CN1190494C System for expressing hyperther mostable protein
02/22/2005US6858776 Plants having modified reproductive capacity
02/22/2005US6858775 Method for generating split, non-transferable genes that are able to express an active protein product
02/22/2005US6858772 Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions
02/22/2005US6858721 Method for producing cytosine nucleoside compounds
02/22/2005US6858718 Hydrogen production
02/22/2005US6858717 Method for obtaining modified polysaccharides
02/22/2005US6858716 Drosophila recombination-associated protein and methods for use
02/22/2005US6858714 Cyclic GMP phosphodiesterase
02/22/2005US6858428 Nutrient broth for use in the suppression of apoptosis
02/22/2005US6858427 Sphingosine kinases
02/22/2005US6858425 Human acid alpha glucosidase gene and bovine alpha-S1 casein gene sequences
02/22/2005US6858422 Lipase genes
02/22/2005US6858421 Antiinflammatory agents; cyclooxygenases; enzyme inhibitors
02/22/2005US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/22/2005US6858419 Comprises phosphorylating protein for diagnosis, prognosis, drug screening, clinical monitoring and treatment of hypertension
02/22/2005US6858418 Polypeptide for use in the treatment of cardiovascular and cell proliferation disorders
02/22/2005US6858417 Dna fragment carrying toluene monooxygenase, gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation
02/22/2005US6858416 Human desaturase gene and uses thereof
02/22/2005US6858415 Comprises enzymatic polypeptide for treatment and diagnsis of muscular, aberrant glycolysis and/or immunological disorders